and intravenous dexamethasone (0.15 mg/kg to a maximum of 16 mg, slowly), in group I and II, respectively. Pain explained by patients, based on VAS (Visual Analogue Scale) was recorded at the time ...

Dexamethasone phosphate (as sodium); 4mg/mL, 10mg/mL; soln for IV or IM inj; contains sulfites. Potentiated by CYP3A4 inhibitors (eg, ketoconazole, macrolides), cyclosporine, estrogens.

In a public alert (No. 06/2025) made available on the agency’s website, NAFDAC revealed that these injections were repacked and mislabelled as Noristerat Injection 200mg. It stated that samples ...

Data from the study showed that the new SC formulation of Sarclisa in combination with Bristol Myers’ BMY Pomalyst (pomalidomide) and dexamethasone (Pd) when administered through an on-body ...

The subcutaneous formulation of daratumumab makes treatment a faster and more tolerable process for patients with multiple ...

Potentiates dexamethasone (reduce its dose by 50%), methylprednisolone (reduce its IV dose by 25% and its oral dose by 50%), midazolam, alprazolam, triazolam. May antagonize warfarin (closely ...

Takeda (TSE:4502/NYSE:TAK) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion for the extension of the ...

The mean age of patients treated with dexamethasone was 36.27 ± 13.38 and in group treated with intravenous propofol was 35.65 ± 12.55 years. Independent T-test results showed no significant ...